Skip to main content
Livermore
Livermore
ZHEN

Commonwealth Equity Services, LLC

SEC CIK
0000312272
Latest filing
Jul 29, 2026

PACB holding history

Pacific Biosciences of California, Inc. in every 13F filed by Commonwealth Equity Services, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PACB overviewAll 13F holders of PACBFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of PACB by Commonwealth Equity Services, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−63,227−100.0%Sold outHolders
Q2 202563,227$78.0K<0.1%−13,135−17.2%ReducedHolders
Q1 202576,362$90.0K<0.1%−350.0%ReducedHolders
Q4 202476,397$140.0K<0.1%−14,924−16.3%ReducedHolders
Q3 202491,321$155.0K<0.1%+78,531+614.0%AddedHolders
Q2 202412,790$18.0K<0.1%−1,080−7.8%ReducedHolders
Q1 202413,870$52.0K<0.1%−1,589−10.3%ReducedHolders
Q4 202315,459$152.0K<0.1%−454−2.9%ReducedHolders
Q3 202315,913$133.0K<0.1%−667−4.0%ReducedHolders
Q2 202316,580$221.0K<0.1%00.0%UnchangedHolders
Q1 202316,580$192.0K<0.1%−185−1.1%ReducedHolders
Q4 202216,765$137.0K<0.1%−19,203−53.4%ReducedHolders
Q3 202235,968$208.0K<0.1%−6,040−14.4%ReducedHolders
Q2 202242,008$185.0K<0.1%−5,828−12.2%ReducedHolders
Q1 202247,836$435.0K<0.1%−2,105−4.2%ReducedHolders
Q4 202149,941$1.02M<0.1%+29,338+142.4%AddedHolders
Q3 202120,603$526.0K<0.1%+3,721+22.0%AddedHolders
Q2 202116,882$590.0K<0.1%+788+4.9%AddedHolders
Q1 202116,094$536.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.